Fig. 1.
Fig. 1. Pattern of expression of bcl-2 family members in human tonsillar B-cell populations (A) and FL cells (B). Samples from (A) FACS-sorted CD38−IgD+ naive B cells, CD38+IgD− GC B cells, and CD38−IgD− memory B cells and (B) samples from highly purified FL cells of five representative patients were lysed and analyzed by SDS-PAGE and Western blotting using: anti–mcl-1 polyclonal antiserum (first panel); anti–bcl-x polyclonal antiserum (second panel); anti–bcl-2 MoAb (third panel); anti–bax polyclonal antiserum (fourth panel); or anti-bad MoAb (fifth panel). Expression of the different proteins was quantitated in each lane using a Scanner phosphoimager (Alpha Innotech Corp, San Leonardo, CA). Jurkat cell line (last lane in A and B), grown in log phase, was used as control. A total of 3 × 106 cell equivalents were used per test. Similar results were obtained when experiments were performed on tonsils or FL cells using an equivalent amount of protein per lane.

Pattern of expression of bcl-2 family members in human tonsillar B-cell populations (A) and FL cells (B). Samples from (A) FACS-sorted CD38IgD+ naive B cells, CD38+IgD GC B cells, and CD38IgD memory B cells and (B) samples from highly purified FL cells of five representative patients were lysed and analyzed by SDS-PAGE and Western blotting using: anti–mcl-1 polyclonal antiserum (first panel); anti–bcl-x polyclonal antiserum (second panel); anti–bcl-2 MoAb (third panel); anti–bax polyclonal antiserum (fourth panel); or anti-bad MoAb (fifth panel). Expression of the different proteins was quantitated in each lane using a Scanner phosphoimager (Alpha Innotech Corp, San Leonardo, CA). Jurkat cell line (last lane in A and B), grown in log phase, was used as control. A total of 3 × 106 cell equivalents were used per test. Similar results were obtained when experiments were performed on tonsils or FL cells using an equivalent amount of protein per lane.

Close Modal

or Create an Account

Close Modal
Close Modal